BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3965366)

  • 1. Infection with the delta agent in children.
    Farci P; Barbera C; Navone C; Bortolotti F; Vajro P; Caporaso N; Vegnente A; Ansaldi N; Rizzetto M; Tolentino P
    Gut; 1985 Jan; 26(1):4-7. PubMed ID: 3965366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of post-transfusion infection with the hepatitis delta virus. A multicenter study.
    Rosina F; Saracco G; Rizzetto M
    N Engl J Med; 1985 Jun; 312(23):1488-91. PubMed ID: 3990749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta infection in children.
    Farci P; Calzia R; Barbera C; Caporaso N; Bortolotti F; Vajro P; Vegnente A
    Prog Clin Biol Res; 1983; 143():225-9. PubMed ID: 6669577
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver cirrhosis associated with chronic hepatitis B virus infection in childhood.
    Bortolotti F; Calzia R; Cadrobbi P; Giacchini R; Ciravegna B; Armigliato M; Piscopo R; Realdi G
    J Pediatr; 1986 Feb; 108(2):224-7. PubMed ID: 3944707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers.
    Arico S; Aragona M; Rizzetto M; Caredda F; Zanetti A; Marinucci G; Diana S; Farci P; Arnone M; Caporaso N
    Lancet; 1985 Aug; 2(8451):356-8. PubMed ID: 2862515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spread of delta infection in a group of haemodialysis carriers of HBsAg.
    Marinucci G; Valeri L; Di Giacomo C; Morganti D
    Prog Clin Biol Res; 1983; 143():151-4. PubMed ID: 6669567
    [No Abstract]   [Full Text] [Related]  

  • 7. [Delta infection in HBsAg carriers].
    Hess G; Slusarczyk J; Hansson BG; Dienes HP; Baumann W; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1984 Dec; 22(12):692-6. PubMed ID: 6396986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.
    Weller IV; Karayiannis P; Lok AS; Montano L; Bamber M; Thomas HC; Sherlock S
    Gut; 1983 Nov; 24(11):1061-3. PubMed ID: 6629117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frequency of delta infections in Heidelberg].
    Gmelin K; Theilmann L; Roggendorf M; Wolf P; Schlipköter U; Czygan P; Kommerell B; Deinhardt F
    Klin Wochenschr; 1985 Feb; 63(4):164-7. PubMed ID: 3884893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta agent infection in Melbourne.
    Hoy JF; Hansson BG; Dimitrakakis M; Gust I; Lucas CR
    J Med Virol; 1984; 13(4):339-45. PubMed ID: 6736942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.
    Craxì A; Raimondo G; Longo G; Giannuoli G; De Pasquale R; Caltagirone M; Patti S; Squadrito G; Pagliaro L
    Gut; 1984 Nov; 25(11):1288-90. PubMed ID: 6500367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with delta agent in Sweden: introduction of a new hepatitis agent.
    Hansson BG; Moestrup T; Widell A; Nordenfelt E
    J Infect Dis; 1982 Oct; 146(4):472-8. PubMed ID: 7119477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of the course of chronic liver diseases of hepatitis B etiology with delta infection in children].
    Chistova LV; Ivanov VG; Khodunova TV; Sakhatov MIa
    Pediatriia; 1991; (10):33-8. PubMed ID: 1787997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta infection in the course of chronic hepatitis B.
    Colombo M; Rumi MG; Donato MF; Rossi A; Dioguardi N
    Prog Clin Biol Res; 1983; 143():203-8. PubMed ID: 6669574
    [No Abstract]   [Full Text] [Related]  

  • 15. Virology and clinical significance of delta agent infection.
    Hansson BG
    J Virol Methods; 1985 Apr; 10(4):295-8. PubMed ID: 3998040
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of delta infection on severity of hepatitis B.
    Smedile A; Farci P; Verme G; Caredda F; Cargnel A; Caporaso N; Dentico P; Trepo C; Opolon P; Gimson A; Vergani D; Williams R; Rizzetto M
    Lancet; 1982 Oct; 2(8305):945-7. PubMed ID: 6127458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment.
    Rizzetto M; Verme G; Recchia S; Bonino F; Farci P; Aricò S; Calzia R; Picciotto A; Colombo M; Popper H
    Ann Intern Med; 1983 Apr; 98(4):437-41. PubMed ID: 6340574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic studies of severe delta agent infection in Venezuelan Indians.
    Popper H; Thung SN; Gerber MA; Hadler SC; de Monzon M; Ponzetto A; Anzola E; Rivera D; Mondolfi A; Bracho A
    Hepatology; 1983; 3(6):906-12. PubMed ID: 6629319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection with the delta agent in chronic HBsAg carriers.
    Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
    Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.